MARTINO, BARBARA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 267
EU - Europa 95
AS - Asia 83
AF - Africa 47
SA - Sud America 38
Totale 530
Nazione #
US - Stati Uniti d'America 265
SG - Singapore 66
IT - Italia 37
BR - Brasile 34
CI - Costa d'Avorio 31
IE - Irlanda 30
SN - Senegal 14
RU - Federazione Russa 8
CN - Cina 6
AR - Argentina 4
UA - Ucraina 4
VN - Vietnam 4
AT - Austria 3
NL - Olanda 3
CA - Canada 2
DE - Germania 2
NG - Nigeria 2
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
FR - Francia 1
GB - Regno Unito 1
HU - Ungheria 1
IN - India 1
IQ - Iraq 1
JO - Giordania 1
MD - Moldavia 1
OM - Oman 1
PL - Polonia 1
RS - Serbia 1
SE - Svezia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 530
Città #
Santa Clara 97
Singapore 48
Chicago 40
Abidjan 31
Dublin 30
Chandler 28
Boardman 14
Dakar 14
Ashburn 9
Civitanova Marche 9
Andover 8
Cambridge 8
Lawrence 8
Des Moines 6
Los Angeles 5
São Paulo 5
Chieri 4
Dong Ket 4
Enna 4
Catanzaro 3
Jacksonville 3
Abuja 2
Catania 2
Córdoba 2
Gravataí 2
Itaquaquecetuba 2
Saint Petersburg 2
Alvorada d'Oeste 1
Amman 1
Amsterdam 1
Ancona 1
Assis 1
Baghdad 1
Baku 1
Baronissi 1
Belgrade 1
Belém 1
Brasília 1
Brno 1
Budapest 1
Buenos Aires 1
Caldas Novas 1
Chisinau 1
Cornate D'adda 1
Den Haag 1
Edinburgh 1
Fairfield 1
Ferraz de Vasconcelos 1
Floridia 1
Fortaleza 1
Frankfurt am Main 1
Gebze 1
Grafing 1
Groningen 1
Guangzhou 1
Ibirité 1
Iguape 1
Inhambupe 1
Itaberaba 1
Leopoldina 1
Luziânia 1
Maipú 1
Manaus 1
Milan 1
Mogi Guaçu 1
Moscow 1
Muscat 1
New York 1
Norwalk 1
Osasco 1
Ottawa 1
Palermo 1
Porto Alegre 1
Pune 1
Ribeira do Pombal 1
Ribeirão Preto 1
San Francisco 1
Santa Rita do Sapucaí 1
São Leopoldo 1
Tashkent 1
Toronto 1
Varginha 1
Verkhovyna 1
Wilmington 1
Xanxerê 1
Xinguara 1
Totale 449
Nome #
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 81
Effects of infections on the patogenesis of cancer 57
Differences among young adults, adults and elderly chronic myeloid leukemia patients 54
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study 51
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data 46
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis 44
Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts 38
The multi-tyrosine kinase inhibitor ponatinib for chronic myeloid leukemia: Real-world data 38
Erratum: Treatment adherence towards prescribed medications in bipolar-II acute depressed patients: Relationship with cyclothymic temperament and "therapeutic sensation seeking" in response towards subjective intolerance to pain" (Journal of Affective Disorders (2013) 151:2 (596-604) DOI:10.1016/j.jad.2013.07.004) 28
Search for secluded dark matter towards the Galactic Centre with the ANTARES neutrino telescope 27
Search for magnetic monopoles with ten years of the ANTARES neutrino telescope 27
Search for solar atmospheric neutrinos with the ANTARES neutrino telescope 25
Search for non-standard neutrino interactions with 10 years of ANTARES data 22
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib 17
Totale 555
Categoria #
all - tutte 2.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.671


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/202123 1 0 1 4 8 1 2 0 1 0 1 4
2021/202249 1 11 0 1 9 1 8 2 1 0 2 13
2022/2023103 8 7 8 5 4 14 0 30 19 1 4 3
2023/202493 4 18 3 3 2 20 0 1 12 9 12 9
2024/2025280 4 62 12 13 72 43 17 6 24 26 1 0
Totale 555